
zzso necrosis factor zzso zzso zzso zzso is a member of the zzso family of zzso Based on its ability to induce zzso selectively in a wide variety of cancer cell lines and human tumor zzso TRAIL has been in drug development as a potential biological agent for cancer zzso A variety of chemotherapy agents have been shown to enhance the zzso effects of zzso The potential benefits of TRAIL as an zzso therapy have been further indicated by its ability to enhance the efficacy of zzso zzso studies have shown the potential use of zzso zzso zzso that selectively bind TRAIL death receptors for cancer zzso This review provides an overview of TRAIL zzso zzso of tumor cells, with TRAIL or zzso zzso zzso only or with chemotherapy zzso Treatment of tumor zzso with these zzso alone or in combination with chemotherapy or radiation, are discussed along with preliminary information about early clinical zzso Additional clinical trials with TRAIL zzso zzso in combination treatment regimens are required to determine their potential for targeted therapy of zzso 

